77 related articles for article (PubMed ID: 11860847)
21. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
[TBL] [Abstract][Full Text] [Related]
22. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
23. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
24. Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy.
Rakozy C; Grignon DJ; Sarkar FH; Sakr WA; Littrup P; Forman J
Mod Pathol; 1998 Sep; 11(9):892-9. PubMed ID: 9758370
[TBL] [Abstract][Full Text] [Related]
25. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
Acta Oncol; 2005; 44(1):75-9. PubMed ID: 15848909
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
Wu W; Zhang X; Yan X; Wang J; Zhang J; Li Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):264-7. PubMed ID: 12515622
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
29. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
30. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
31. P53 and PCNA immunoexpression in endometrial carcinomas.
Simionescu C; Georgescu CV; Mărgăritescu C; Bălă S; Marinescu M; Enăchescu V; Pătru E
Rom J Morphol Embryol; 2006; 47(2):137-41. PubMed ID: 17106521
[TBL] [Abstract][Full Text] [Related]
32. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
33. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
[TBL] [Abstract][Full Text] [Related]
34. Expression of p21 in non small cell lung cancer relationship with PCNA.
Groeger AM; Caputi M; Esposito V; Baldi A; Rossiello R; Santini D; Mancini A; Kaiser HE; Baldi F
Anticancer Res; 2000; 20(5A):3301-5. PubMed ID: 11062757
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results.
Bektas A; Yasa MH; Kuzu I; Dogan I; Unal S; Ormeci N
Hepatogastroenterology; 2001; 48(38):408-12. PubMed ID: 11379319
[TBL] [Abstract][Full Text] [Related]
36. [The expression of proliferating cell nuclear antigen and p53 protein in salivary gland tumours].
Tian Y; Wang Z; Zhong M
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):177-9. PubMed ID: 10680534
[TBL] [Abstract][Full Text] [Related]
37. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.
Warbrick E; Lane DP; Glover DM; Cox LS
Curr Biol; 1995 Mar; 5(3):275-82. PubMed ID: 7780738
[TBL] [Abstract][Full Text] [Related]
38. Human and plant proliferating-cell nuclear antigen have a highly conserved binding site for the p53-inducible gene product p21WAF1.
Ball KL; Lane DP
Eur J Biochem; 1996 May; 237(3):854-61. PubMed ID: 8647134
[TBL] [Abstract][Full Text] [Related]
39. [Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin].
Zeng R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(5):349-52, 356. PubMed ID: 27382672
[TBL] [Abstract][Full Text] [Related]
40. Discordant hepatic expression of the cell division control enzyme p34cdc2 kinase, proliferating cell nuclear antigen, p53 tumor suppressor protein, and p21Waf1 cyclin-dependent kinase inhibitory protein after WY14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) dosing to rats.
Ma X; Stoffregen DA; Wheelock GD; Rininger JA; Babish JG
Mol Pharmacol; 1997 Jan; 51(1):69-78. PubMed ID: 9016348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
